A study conducted by Hartman et al. to evaluate the potential effect of TZT on the biomarkers of non-alcoholic steatohepatitis in T2DM patients showed that TZT treatment increases adiponectin and reduces related inflammation in T2DM patients. Here, ADIPOQ is linked to type 2 diabetes mellitus.